RSS-Feed abonnieren
DOI: 10.1055/s-0029-1224133
© Georg Thieme Verlag KG Stuttgart · New York
The Value of Immunoassays for Metanephrines in the Biochemical Diagnosis of Pheochromocytomas
Publikationsverlauf
received 18.12.2008
accepted 24.04.2009
Publikationsdatum:
25. Juni 2009 (online)

Abstract
An undiagnosed pheochromocytoma may result in life-threatening consequences. The diagnosis of pheochromocytoma is based on the overproduction of catecholamines. Highly sensitive biochemical assays are essential to avoid false-negative results. Determinations of 24-h urinary epinephrine and norepinephrine levels are established diagnostic tools. However, they may be falsely negative in patients with a biochemically-silent or periodically-secreting pheochromocytoma. Metanephrines, which are metabolites of catecholamines, have been suggested as an alternative diagnostic tool. Urinary metanephrines are determined by high-pressure liquid chromatography (HPLC) in an increasing number of laboratories, whereas plasma metanephrines measured by HPLC are available in specialised centres only. The different HPLC methods may be cost- and time-intensive. Immunoassays such as radio- or enzyme-immunoassays may be alternative procedures. Measurement of metanephrines instead of catecholamines by either technique improved the diagnostic accuracy for the diagnosis of pheochromocytomas. Determination of plasma free metanephrines demonstrated a higher accuracy than their urinary counterparts. The use of immunoassays may be an alternative to the laborious HPLC, although the method needs to be evaluated in more detail.
Key words
plasma metanephrines - urinary metanephrines - pheochromocytoma - HPLC - immunoassays
References
- 1
Eisenhofer G, Walther M, Keiser HR, Lenders JW, Friberg P, Pacak K.
Plasma metanephrines: a novel and cost-effective test for phaeochromocytoma.
Braz J Med Biol Res.
2000;
33
1157-1169
MissingFormLabel
- 2
Eisenhofer G.
Editorial: biochemical diagnosis of phaeochromocytoma – is it time to switch to plasma-free
metanephrines?.
J Clin Endocrinol Metab.
2003;
88
550-552
MissingFormLabel
- 3
Roden M.
How to detect phaeochromocytomas? – the diagnostic relevance of plasma free metanephrines.
Wien Klin Wochenschr.
2002;
114
246-251
MissingFormLabel
- 4
Sawka AM, Prebtani AP, Thabane L, Gafni A, Levine M, Young Jr WF.
A systematic review of the literature examining the diagnostic efficacy of measurement
of fractionated plasma free metanephrines in the biochemical diagnosis of phaeochromocytoma.
BMC Endocr Disord.
2004;
4
2
MissingFormLabel
- 5
Eisenhofer G, Keiser H, Friberg P, Mezey E, Huynh TT, Hiremagalur B, Ellingson T, Duddempudi S, Eijsbouts A, Lenders JW.
Plasma metanephrines are markers of phaeochromocytoma produced by catechol-O-methyltransferase
within tumors.
J Clin Endocrinol Metab.
1998;
83
2175-2185
MissingFormLabel
- 6
Eisenhofer G, Siegert G, Kotzerke J, Bornstein SR, Pacak K.
Current progress and future challenges in the biochemical diagnosis and treatment
of phaeochromocytomas and paragangliomas.
Horm Metab Res.
2008;
40
329-337
MissingFormLabel
- 7
Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, Keiser HR, Goldstein DS, Eisenhofer G.
Biochemical diagnosis of phaeochromocytoma: which test is best?.
JAMA.
2002;
287
1427-1434
MissingFormLabel
- 8
Lenders JW, Keiser HR, Goldstein DS, Willemsen JJ, Friberg P, Jacobs MC, Kloppenborg PW, Thien T, Eisenhofer G.
Plasma metanephrines in the diagnosis of phaeochromocytoma.
Ann Intern Med.
1995;
123
101-109
MissingFormLabel
- 9
Sawka AM, Jaeschke R, Singh RJ, Young Jr WF.
A comparison of biochemical tests for phaeochromocytoma: measurement of fractionated
plasma metanephrines compared with the combination of 24-hour urinary metanephrines
and catecholamines.
J Clin Endocrinol Metab.
2003;
88
553-558
MissingFormLabel
- 10
Raber W, Raffesberg W, Bischof M, Scheuba C, Niederle B, Gasic S, Waldhausl W, Roden M.
Diagnostic efficacy of unconjugated plasma metanephrines for the detection of phaeochromocytoma.
Arch Intern Med.
2000;
160
2957-2963
MissingFormLabel
- 11
Unger N, Pitt C, Schmidt IL, Walz MK, Schmid KW, Philipp T, Mann K, Petersenn S.
Diagnostic value of various biochemical parameters for the diagnosis of phaeochromocytoma
in patients with adrenal mass.
Eur J Endocrinol.
2006;
154
409-417
MissingFormLabel
- 12
Gao YC, Lu HK, Luo QY, Chen LB, Ding Y, Zhu RS.
Comparison of free plasma metanephrines enzyme immunoassay with (131)I-MIBG scan in
diagnosis of phaeochromocytoma.
Clin Exp Med.
2008;
8
87-91
MissingFormLabel
- 13
Lenz T, Zorner J, Kirchmaier C, Pillitteri D, Badenhoop K, Bartel C, Geiger H, Hasselbacher K, Tuschy U, Westermann J, Salewski L.
Multicenter study on the diagnostic value of a new RIA for the detection of free plasma
metanephrines in the work-up for phaeochromocytoma.
Ann N Y Acad Sci.
2006;
1073
358-373
MissingFormLabel
- 14
Eisenhofer G, Goldstein DS, Walther MM, Friberg P, Lenders JW, Keiser HR, Pacak K.
Biochemical diagnosis of phaeochromocytoma: how to distinguish true- from false-positive
test results.
J Clin Endocrinol Metab.
2003;
88
2656-2666
MissingFormLabel
- 15
Gardet V, Gatta B, Simonnet G, Tabarin A, Chene G, Ducassou D, Corcuff JB.
Lessons from an unpleasant surprise: a biochemical strategy for the diagnosis of phaeochromocytoma.
J Hypertens.
2001;
19
1029-1035
MissingFormLabel
- 16
Eisenhofer G.
Free or total metanephrines for diagnosis of phaeochromocytoma: what is the difference?.
Clin Chem.
2001;
47
988-989
MissingFormLabel
- 17
Eisenhofer G, Huynh TT, Hiroi M, Pacak K.
Understanding catecholamine metabolism as a guide to the biochemical diagnosis of
phaeochromocytoma.
Rev Endocr Metab Disord.
2001;
2
297-311
MissingFormLabel
- 18
Feldman JM.
Falsely elevated urinary excretion of catecholamines and metanephrines in patients
receiving labetalol therapy.
J Clin Pharmacol.
1987;
27
288-292
MissingFormLabel
- 19
Lenders JW, Eisenhofer G, Armando I, Keiser HR, Goldstein DS, Kopin IJ.
Determination of metanephrines in plasma by liquid chromatography with electrochemical
detection.
Clin Chem.
1993;
39
97-103
MissingFormLabel
- 20
Roden M, Raffesberg W, Raber W, Bernroider E, Niederle B, Waldhausl W, Gasic S.
Quantification of unconjugated metanephrines in human plasma without interference
by acetaminophen.
Clin Chem.
2001;
47
1061-1067
MissingFormLabel
- 21
Wassell J, Reed P, Kane J, Weinkove C.
Freedom from drug interference in new immunoassays for urinary catecholamines and
metanephrines.
Clin Chem.
1999;
45
2216-2223
MissingFormLabel
- 22
Lenders JW, Willemsen JJ, Eisenhofer G, Ross HA, Pacak K, Timmers HJ, Sweep CG.
Is supine rest necessary before blood sampling for plasma metanephrines?.
Clin Chem.
2007;
53
352-354
MissingFormLabel
- 23
Eisenhofer G, Lenders JW, Linehan WM, Walther MM, Goldstein DS, Keiser HR.
Plasma normetanephrine and metanephrine for detecting phaeochromocytoma in von Hippel-Lindau
disease and multiple endocrine neoplasia type 2.
N Engl J Med.
1999;
340
1872-1879
MissingFormLabel
Correspondence
S. PetersennMD
Division of Endocrinology, Medical Center
University of Duisburg-Essen
Hufelandstraße 55
45122 Essen
Germany
Telefon: +49/201/723 28 54
Fax: +49/201/723 59 76
eMail: stephan.petersenn@uni-due.de